The Covid-19 epidemic is picking up steam as summer approaches. Logically supported by Omicron’s new sub-variant, BA.5, which is more transmissible and still expanding (more than 18% of tests screened according to the latest national data available, compared to 5% last week former).
The incidence rate is thus increasing at the national level (305/100,000 inhabitants on June 10, up 27% over one week), as in our departments, where the Rhône has the highest rate (288/100,000 , nearly 30% more than a week earlier).
–
Hospitalizations: still stable or decreasing
Hospitalizations of people with a Covid-19 diagnosis remain stable or down in the 5 departments. The Haute-Loire or the Rhône, which have fallen below the threshold of 300 people hospitalized for 10 days, have halved this number in less than two months, since the last peak recorded in the middle of April. In the Jura, we have to go back to mid-November 2021 to see such a low number of people hospitalized (37 to June 13).
–
Critical care: ever fewer people in the Rhône
The observation is the same in intensive care units, where the situation is stable at low levels in Ain, Haute-Loire and Jura, or falling in Rhône. The improvement in the situation is particularly clear in the latter department, where there have not been so few people in intensive care since July 2021 and where these health indicators are now at the same level as in the neighboring Loire.
–
Below the threshold of ten weekly deaths
Our 5 departments total less than ten hospital deaths for the 3rd consecutive week: there are indeed 9 from May 23 to 29, 9 from May 30 to June 5 and 8 from June 6 to 12. In total, the pandemic has caused the death of 7,785 people hospitalized with a Covid-19 diagnosis in our departments.
–
Vaccination: no race for the booster dose
On the vaccination front, the status quo prevails or almost. Including for the 2nd booster dose, open since the beginning of April to people aged 60 to 79 years 6 months after the first booster injection or from 6 months after the last infection (over 80s and severely immunocompromised people were eligible since March and January). It is in the Rhône that this recommendation finds the greatest echo, with a quarter of more than 80 years having crossed the course and 18.9% of the 75/79 years.
–
